Venus Concept Announces First Quarter of Fiscal Year 2024 Financial Results
GlobeNewswire
TORONTO, May 15, 2024 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global..
TORONTO, May 15, 2024 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global..
The proposed sensor has the potential to not only revolutionize COPD management but also to impact healthcare by incorporating..
· Long term extension of the Phase 2 VISIONARY-MS clinical trial of CNM-Au8 demonstrated significant evidence of repair and..